Mammary Cell News Volume 16.03 | Jan 25 2024

    0
    9








    2024-01-26 | MCN 16.03


    Mammary Cell News by STEMCELL Technologies
    Vol. 16.03 – 25 January, 2024
    TOP STORY

    Overall Survival with Palbociclib Plus Letrozole in Advanced Breast Cancer

    Researchers reported results for the secondary end point overall survival. Postmenopausal women with ER+/HER2 advanced breast cancer (ABC) without previous systemic therapy for ABC were randomly assigned 2:1 to palbociclib plus letrozole or placebo plus letrozole.
    [Journal Of Clinical Oncology]

    Full Article
    Webinar on Modeling arrhythmias using hPSC-derived cardiomyocytes
    PUBLICATIONSRanked by the impact factor of the journal

    The Breast Cancer Coagulome in the Tumor Microenvironment and Its Role in Prognosis and Treatment Response to Chemotherapy

    Scientists investigated the breast tumor coagulome and its relation to prognosis, treatment response to chemotherapy, and the tumor microenvironment.
    [Journal Of Thrombosis And Haemostasis]

    Abstract

    A Second-Generation eIF4A RNA Helicase Inhibitor Exploits Translational Reprogramming as a Vulnerability in Triple-Negative Breast Cancer

    Investigators developed an orally bioavailable rocaglate-based molecule, MG-002, which hindered ribosome recruitment and scanning via unscheduled and non-productive RNA clamping by the eukaryotic translation initiation factor 4A RNA helicase.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    The Extracellular Matrix Supports Breast Cancer Cell Growth under Amino Acid Starvation by Promoting Tyrosine Catabolism

    The authors demonstrated that the presence of extracellular matrix (ECM) supported the growth of invasive breast cancer cells, but not non-transformed mammary epithelial cells, under amino acid starvation, through a mechanism that required macropinocytosis-dependent ECM uptake.
    [PLOS Biology]

    Full Article

    HDAC Inhibitors Target IRS4 to Enhance Anti-AR Therapy in AR-Positive Triple-Negative Breast Cancer

    A combination of an androgen receptor (AR) inhibitor and a selective histone deacetylase inhibitor was used to treat AR‑positive TNBC cell lines, and a synergistic effect of these drugs was observed.
    [International Journal Of Oncology]

    Full Article

    Conditional In Vivo Deletion of LYN Kinase Has Little Effect on a BRCA1 Loss-of-Function-Associated Mammary Tumor Model

    The authors examined the interaction between LYN kinase and BRCA1 loss-of-function in an in vivo mouse mammary tumor model, using conditional knockout Brca1 and Lyn alleles.
    [Disease Models & Mechanisms]

    Full Article

    Investigation of Co-Treatment Multi-Targeting Approaches in Breast Cancer Cell Lines

    Researchers evaluated different treatment approaches in breast cancer cells. The expression of some membrane markers relevant to resistance was assessed.
    [European Journal Of Pharmacology]

    Abstract

    Bioinformatic Analysis Reveals an Association between Metadherin with Breast Cancer Prognosis and Tumor Immune Infiltration

    Investigators found that Metadherin was overexpressed in breast cancer and was significantly correlated with individual cancer stage, age, subclasses, menopause and nodal metastasis status.
    [Scientific Reports]

    Full Article

    CGA Alleviates LPS-Induced Inflammation and Milk Fat Reduction in BMECs through the NF-κB Signaling Pathway

    Scientists explored whether chlorogenic acid attenuated lipopolysaccharide-induced inflammation and decreased milk fat in bovine mammary epithelial cells.
    [Heliyon]

    Full Article
    See how small molecules affect key signaling pathways in cancer research. Download your free wallchart now.
    REVIEWS

    Cell-Cell Communication Characteristics in Breast Cancer Metastasis

    The authors provide a comprehensive overview of the characteristics of breast cancer metastases, shedding light on the pivotal roles of immune and resident cells in the development of distinct metastatic foci.
    [Cell Communication And Signaling]

    Full ArticleGraphical Abstract

    New Insight into the Role of the ADAM Protease Family in Breast Carcinoma Progression

    Scientists discuss the mechanism of action of various a disintegrin and metalloproteas (ADAM) molecules, their relation to pathogenic processes of breast cancer, and their potential as possible targets for breast cancer treatment.
    [Heliyon]

    Full Article
    INDUSTRY AND POLICY NEWS

    Mammograms Are Less Effective for Women with Dense Breast Tissue. Medical Experts Disagree on What to Do about It

    Millions of American women over age 40 receive regular mammograms to screen for breast cancer. About half of them turn out to have dense breast tissue — which makes screening significantly more complicated.
    [STAT]

    Press Release

    Why Are Researchers Launching Breast Cancer Cells Into Space?

    Researchers from the University of California San Diego are using cancerous tumor grown using cells from breast cancer patients to explore the effectiveness of certain cancer treatments. The lack of gravity strains the cells and can speed up the aging process.
    [The Messenger]

    Press Release
    FEATURED EVENT

    3D Cell Culture & Organ Modeling 2024

    March 18 – 19, 2024
    London, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Full Professor – Breast Surgical Oncology

    Sunnybrook Health Science Centre – Toronto, Ontario, Canada

    Postdoctoral Researchers – Advanced Imaging & 3D Genome Analysis in Cancer Biology

    Karolinska Institutet – Solna, Sweden

    Research Fellow – Structural Biology of RNA

    University of Birmingham – Birmingham, England, United Kingdom

    Postdoctoral Research Associate – Morphogenesis of the Lung and Mammary Gland

    Princeton University – Princeton, New Jersey, United States

    Postdoctoral Researcher – Computational Cancer Evolution

    Human Technopole – Milan, Italy

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2